Press release
Procalcitonin (CAS 56645-65-9) Market Expected to Deliver Dynamic Progression until 2027| Medical Industry, Scientific Research, Veterinarian
Each segment of the global Procalcitonin (CAS 56645-65-9) market is extensively evaluated in the research study. The segmental analysis offered in the report pinpoints key opportunities available in the global Procalcitonin (CAS 56645-65-9) market through leading segments. The regional study of the global Procalcitonin (CAS 56645-65-9) market included in the report helps readers to gain a sound understanding of the development of different geographical markets in recent years and also going forth. We have provided a detailed study on the critical dynamics of the global Procalcitonin (CAS 56645-65-9) market, which include the market influence and market effect factors, drivers, challenges, restraints, trends, and prospects. The research study also includes other types of analysis such as qualitative and quantitative.
Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/sample-form/form/2711020/global-procalcitonin-cas-56645-65-9-market
Global Procalcitonin (CAS 56645-65-9) Market: Competitive Rivalry
The chapter on company profiles studies the various companies operating in the global Procalcitonin (CAS 56645-65-9) market. It evaluates the financial outlooks of these companies, their research and development statuses, and their expansion strategies for the coming years. Analysts have also provided a detailed list of the strategic initiatives taken by the Procalcitonin (CAS 56645-65-9) market participants in the past few years to remain ahead of the competition.
Key players cited in the report: Medical Industry, Scientific Research, Veterinarian, The medical industry holds an important share in terms of applications, and accounts for 90% of the market share.
Global Procalcitonin (CAS 56645-65-9) Market: Type Segments: Procalcitonin Antigen, Procalcitonin Antibody, The segment of antigen holds a comparatively larger share in global market, which accounts for about 70%.
Global Procalcitonin (CAS 56645-65-9) Market: Application Segments: Medical Industry, Scientific Research, Veterinarian, The medical industry holds an important share in terms of applications, and accounts for 90% of the market share. By Region, North America, U.S., Canada, Europe, Germany, France, U.K., Italy, Russia, Asia-Pacific, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Latin America, Mexico, Brazil, Argentina, Middle East & Africa, Turkey, Saudi Arabia, U.A.E By Company, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology, Wuhan Easy Diagnosis Biomedicine, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Nanjing Norman Biological Technology, Kitgen, Beijing KeyGen, Beijing Apis
Global Procalcitonin (CAS 56645-65-9) Market: Regional Segments
The chapter on regional segmentation details the regional aspects of the global Procalcitonin (CAS 56645-65-9) market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and the anticipates its influence on the global Procalcitonin (CAS 56645-65-9) market.
• The Middle East and Africa (GCC Countries and Egypt)
• North America (the United States, Mexico, and Canada)
• South America (Brazil etc.)
• Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
• Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
Enquire for customization in Report @
https://www.qyresearch.com/customize-request/form/2711020/global-procalcitonin-cas-56645-65-9-market
Report Highlights
• Comprehensive pricing analysis on the basis of product, application, and regional segments
• The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Procalcitonin (CAS 56645-65-9) market
• Deep insights about regulatory and investment scenarios of the global Procalcitonin (CAS 56645-65-9) market
• Analysis of market effect factors and their impact on the forecast and outlook of the global Procalcitonin (CAS 56645-65-9) market
• A roadmap of growth opportunities available in the global Procalcitonin (CAS 56645-65-9) market with the identification of key factors
• The exhaustive analysis of various trends of the global Procalcitonin (CAS 56645-65-9) market to help identify market developments
Table of Contents
1 Procalcitonin (CAS 56645-65-9) Market Overview
1.1 Product Overview and Scope of Procalcitonin (CAS 56645-65-9)
1.2 Procalcitonin (CAS 56645-65-9) Segment by Type
1.2.1 Global Procalcitonin (CAS 56645-65-9) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin (CAS 56645-65-9) Segment by Application
1.3.1 Procalcitonin (CAS 56645-65-9) Sales Comparison by Application: (2021-2027)
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Global Procalcitonin (CAS 56645-65-9) Market Size Estimates and Forecasts
1.4.1 Global Procalcitonin (CAS 56645-65-9) Revenue 2016-2027
1.4.2 Global Procalcitonin (CAS 56645-65-9) Sales 2016-2027
1.4.3 Procalcitonin (CAS 56645-65-9) Market Size by Region: 2016 Versus 2021 Versus 2027 2 Procalcitonin (CAS 56645-65-9) Market Competition by Manufacturers
2.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Procalcitonin (CAS 56645-65-9) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Procalcitonin (CAS 56645-65-9) Manufacturing Sites, Area Served, Product Type
2.5 Procalcitonin (CAS 56645-65-9) Market Competitive Situation and Trends
2.5.1 Procalcitonin (CAS 56645-65-9) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Procalcitonin (CAS 56645-65-9) Players Market Share by Revenue
2.5.3 Global Procalcitonin (CAS 56645-65-9) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Procalcitonin (CAS 56645-65-9) Retrospective Market Scenario by Region
3.1 Global Procalcitonin (CAS 56645-65-9) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Procalcitonin (CAS 56645-65-9) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Procalcitonin (CAS 56645-65-9) Market Facts & Figures by Country
3.3.1 North America Procalcitonin (CAS 56645-65-9) Sales by Country
3.3.2 North America Procalcitonin (CAS 56645-65-9) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Procalcitonin (CAS 56645-65-9) Market Facts & Figures by Country
3.4.1 Europe Procalcitonin (CAS 56645-65-9) Sales by Country
3.4.2 Europe Procalcitonin (CAS 56645-65-9) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Procalcitonin (CAS 56645-65-9) Market Facts & Figures by Region
3.5.1 Asia Pacific Procalcitonin (CAS 56645-65-9) Sales by Region
3.5.2 Asia Pacific Procalcitonin (CAS 56645-65-9) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Procalcitonin (CAS 56645-65-9) Market Facts & Figures by Country
3.6.1 Latin America Procalcitonin (CAS 56645-65-9) Sales by Country
3.6.2 Latin America Procalcitonin (CAS 56645-65-9) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Procalcitonin (CAS 56645-65-9) Market Facts & Figures by Country
3.7.1 Middle East and Africa Procalcitonin (CAS 56645-65-9) Sales by Country
3.7.2 Middle East and Africa Procalcitonin (CAS 56645-65-9) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E 4 Global Procalcitonin (CAS 56645-65-9) Historic Market Analysis by Type
4.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Type (2016-2021)
4.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Type (2016-2021)
4.3 Global Procalcitonin (CAS 56645-65-9) Price by Type (2016-2021) 5 Global Procalcitonin (CAS 56645-65-9) Historic Market Analysis by Application
5.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Application (2016-2021)
5.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Application (2016-2021)
5.3 Global Procalcitonin (CAS 56645-65-9) Price by Application (2016-2021) 6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Thermo Fisher Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Roche Diagnostics
6.2.1 Roche Diagnostics Corporation Information
6.2.2 Roche Diagnostics Description and Business Overview
6.2.3 Roche Diagnostics Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Roche Diagnostics Product Portfolio
6.2.5 Roche Diagnostics Recent Developments/Updates
6.3 bioMerieux
6.3.1 bioMerieux Corporation Information
6.3.2 bioMerieux Description and Business Overview
6.3.3 bioMerieux Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 bioMerieux Product Portfolio
6.3.5 bioMerieux Recent Developments/Updates
6.4 HyTest
6.4.1 HyTest Corporation Information
6.4.2 HyTest Description and Business Overview
6.4.3 HyTest Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 HyTest Product Portfolio
6.4.5 HyTest Recent Developments/Updates
6.5 BBI Solutions
6.5.1 BBI Solutions Corporation Information
6.5.2 BBI Solutions Description and Business Overview
6.5.3 BBI Solutions Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 BBI Solutions Product Portfolio
6.5.5 BBI Solutions Recent Developments/Updates
6.6 ProSpec
6.6.1 ProSpec Corporation Information
6.6.2 ProSpec Description and Business Overview
6.6.3 ProSpec Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 ProSpec Product Portfolio
6.6.5 ProSpec Recent Developments/Updates
6.7 Wondfo
6.6.1 Wondfo Corporation Information
6.6.2 Wondfo Description and Business Overview
6.6.3 Wondfo Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Wondfo Product Portfolio
6.7.5 Wondfo Recent Developments/Updates
6.8 Ningbo Medicalsystem Biotechnology
6.8.1 Ningbo Medicalsystem Biotechnology Corporation Information
6.8.2 Ningbo Medicalsystem Biotechnology Description and Business Overview
6.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ningbo Medicalsystem Biotechnology Product Portfolio
6.8.5 Ningbo Medicalsystem Biotechnology Recent Developments/Updates
6.9 Wuhan Easy Diagnosis Biomedicine
6.9.1 Wuhan Easy Diagnosis Biomedicine Corporation Information
6.9.2 Wuhan Easy Diagnosis Biomedicine Description and Business Overview
6.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Wuhan Easy Diagnosis Biomedicine Product Portfolio
6.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments/Updates
6.10 Snibe
6.10.1 Snibe Corporation Information
6.10.2 Snibe Description and Business Overview
6.10.3 Snibe Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Snibe Product Portfolio
6.10.5 Snibe Recent Developments/Updates
6.11 Vazyme Biotech
6.11.1 Vazyme Biotech Corporation Information
6.11.2 Vazyme Biotech Procalcitonin (CAS 56645-65-9) Description and Business Overview
6.11.3 Vazyme Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Vazyme Biotech Product Portfolio
6.11.5 Vazyme Biotech Recent Developments/Updates
6.12 Getein Biotech
6.12.1 Getein Biotech Corporation Information
6.12.2 Getein Biotech Procalcitonin (CAS 56645-65-9) Description and Business Overview
6.12.3 Getein Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Getein Biotech Product Portfolio
6.12.5 Getein Biotech Recent Developments/Updates
6.13 Hotgen Biotech
6.13.1 Hotgen Biotech Corporation Information
6.13.2 Hotgen Biotech Procalcitonin (CAS 56645-65-9) Description and Business Overview
6.13.3 Hotgen Biotech Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Hotgen Biotech Product Portfolio
6.13.5 Hotgen Biotech Recent Developments/Updates
6.14 Lumigenex
6.14.1 Lumigenex Corporation Information
6.14.2 Lumigenex Procalcitonin (CAS 56645-65-9) Description and Business Overview
6.14.3 Lumigenex Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Lumigenex Product Portfolio
6.14.5 Lumigenex Recent Developments/Updates
6.15 Nanjing Norman Biological Technology
6.15.1 Nanjing Norman Biological Technology Corporation Information
6.15.2 Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Description and Business Overview
6.15.3 Nanjing Norman Biological Technology Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Nanjing Norman Biological Technology Product Portfolio
6.15.5 Nanjing Norman Biological Technology Recent Developments/Updates
6.16 Kitgen
6.16.1 Kitgen Corporation Information
6.16.2 Kitgen Procalcitonin (CAS 56645-65-9) Description and Business Overview
6.16.3 Kitgen Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Kitgen Product Portfolio
6.16.5 Kitgen Recent Developments/Updates
6.17 Beijing KeyGen
6.17.1 Beijing KeyGen Corporation Information
6.17.2 Beijing KeyGen Procalcitonin (CAS 56645-65-9) Description and Business Overview
6.17.3 Beijing KeyGen Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Beijing KeyGen Product Portfolio
6.17.5 Beijing KeyGen Recent Developments/Updates
6.18 Beijing Apis
6.18.1 Beijing Apis Corporation Information
6.18.2 Beijing Apis Procalcitonin (CAS 56645-65-9) Description and Business Overview
6.18.3 Beijing Apis Procalcitonin (CAS 56645-65-9) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Beijing Apis Product Portfolio
6.18.5 Beijing Apis Recent Developments/Updates 7 Procalcitonin (CAS 56645-65-9) Manufacturing Cost Analysis
7.1 Procalcitonin (CAS 56645-65-9) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Procalcitonin (CAS 56645-65-9)
7.4 Procalcitonin (CAS 56645-65-9) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Procalcitonin (CAS 56645-65-9) Distributors List
8.3 Procalcitonin (CAS 56645-65-9) Customers 9 Procalcitonin (CAS 56645-65-9) Market Dynamics
9.1 Procalcitonin (CAS 56645-65-9) Industry Trends
9.2 Procalcitonin (CAS 56645-65-9) Growth Drivers
9.3 Procalcitonin (CAS 56645-65-9) Market Challenges
9.4 Procalcitonin (CAS 56645-65-9) Market Restraints 10 Global Market Forecast
10.1 Procalcitonin (CAS 56645-65-9) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Procalcitonin (CAS 56645-65-9) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Procalcitonin (CAS 56645-65-9) by Type (2022-2027)
10.2 Procalcitonin (CAS 56645-65-9) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Procalcitonin (CAS 56645-65-9) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Procalcitonin (CAS 56645-65-9) by Application (2022-2027)
10.3 Procalcitonin (CAS 56645-65-9) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Procalcitonin (CAS 56645-65-9) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Procalcitonin (CAS 56645-65-9) by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
In order To Purchase This Report Query Click Here: https://www.qyresearch.com/settlement/pre/22257ddd323bf8b5e01391b48d115294,0,1,global-procalcitonin-cas-56645-65-9-market
Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Procalcitonin (CAS 56645-65-9) Market Expected to Deliver Dynamic Progression until 2027| Medical Industry, Scientific Research, Veterinarian here
News-ID: 2455265 • Views: …
More Releases from QY Research, Inc
Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales P …
High Pressure Commercial Toilet also means pressure-flushing toilets. Pressure-flushing toilets are especially common in cities in the U.S. The ceramic tank is not used as a water tank. It holds a plastic pressure vessel of maybe one-third to one-half the ceramic tank"s volume. That pressure tank contains a sealed air bladder. When the tank is filled from the water supply line, the tank fills with water until the air bladder…
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and …
Twin-Screw Pumps is a displacement pump consisting of a casing containing two parallel screws with intermeshing threads fitted to prevent backward movement of fluid
The global Twin-Screw Pumps market was valued at US$ 503 million in 2023 and is anticipated to reach US$ 629 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The top five global producers of twin-screw pumps are Colfax, ITT Bornemann, Flowserve, SPX Flow…
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, …
A strain gauge (or strain gage) is a sensor whose resistance varies with applied force; it converts force, pressure, tension, weight, etc., into a change in electrical resistance which can then be measured. When external forces are applied to a stationary object, stress and strain are the result. Stress is defined as the object"s internal Strain Gauge forces, and strain is defined as the displacement and deformation that occur.
The global…
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Project …
Automatic soap dispensers (also known as touchless or no-touch soap dispensers) dispense a controlled amount of soap solution (or a similar liquid such as a hand sanitizer). They are often used in conjunction with automatic faucets in public restrooms. They function to conserve the amount of soap used and stem infectious disease transmission.
The global Automatic Soap Dispensers market was valued at US$ million in 2023 and is anticipated to reach…
More Releases for Procalcitonin
Procalcitonin (CAS 56645-65-9) Market 2021 | Detailed Report
The Procalcitonin (CAS 56645-65-9) research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Procalcitonin (CAS 56645-65-9) research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Get Free Sample PDF…
Industry Outlook of Procalcitonin Market 2021 | Procalcitonin Tests Will Benefit …
Straits Research Latest 2021 Report: The Global Procalcitonin Market Research Report represents a comprehensive study on the Procalcitonin industry including current trends and status.
The report can help to understand the market in-depth and strategize for business expansion accordingly in the future. In the strategic analysis process, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the…
BRAHMS Procalcitonin Market Size, Share, Development by 2024
Global Info Research offers a latest published report on BRAHMS Procalcitonin Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global BRAHMS Procalcitonin players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the BRAHMS Procalcitonin with respect to individual growth…
Procalcitonin Antibody Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Procalcitonin Antibody market.
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue,…
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
Procalcitonin Antibody Market Outlook, and Opportunity Analysis, 2018 - 2026
Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of 14.5 kDa. It can be segregated into three parts, namely immature calcitonin, calcitonin carboxyl-terminus peptide-1, and amino terminus of the PCT region. Procalcitonin was first classified by Bernard Roos and Leonard J. Deftos in the early 1970s. Procalcitonin…
